The United States has repeatedly expanded the "entity list" of export controls-the small science of the entity list.

Release time:

2023-09-11 14:43

In recent years, the number of entities listed in the United States has increased, shifting from a single national security consideration to more ideological, forced labor and intellectual property issues. The United States has repeatedly used the Department of Commerce's Entity List (Entity List), the Treasury Department's Sanctions List (which includes the "Specially Designated Nationals List", "Comprehensive Sanctions List", "Additional Sanctions List", etc.), and presidential decrees to suppress China-related industries. Without providing any evidence, the United States included more than 600 Chinese enterprises and institutions in the "entity list", intending to cut off the channels for Chinese science and technology enterprises to obtain the technology, equipment, capital and manpower needed for development.

What is the US Entity List?

The U.S. Entity List is a trade blacklist established by the U.S. Department of Commerce's Bureau of Industry and Security that the United States includes foreign entities when they are reasonably determined to be involved or have a significant risk of being involved in a violation of U.S. national security or foreign policy interests. The Entity List is updated and revised by the End-User Review committee (ERC).

The list of entities consists of foreign entities other than the United States, including: 1) foreign enterprises; 2) research institutions; 3) governments; 4) civil society organizations; and 5) individuals and other entities or individuals in the legal sense.

The list of U.S. entities is updated dynamically, and the most restricted countries and regions are Russia, China, the United Arab Emirates and Hong Kong.

Effect of inclusion in the list of entities:

Companies included in the list need to obtain a separate license from the U.S. Department of Commerce to purchase technology or goods controlled by the United States. Exporters may not assist listed entities to obtain any EAR-controlled items (including EAR99 items) without obtaining a license, I .e. to export, re-export or transfer EAR-controlled items to such foreign entities, they must apply for an export license from the United States.

Export or re-export to the Entity List does not apply to any licensing exception, directly applying the principle of the presumption of refusal of license (Policy of Presumption of Denial)

Our company has carried out the monitoring and translation of the US entity list. Interested customers are welcome to contact us for details.

Turkish Chemical Registration KKDIK Registration Extension Draft Released

Turkey's KKDIK End-of -2023 Deadline Approaching, Lead Registration Slow

Turkish Chemical Registration KKDIK Registration Extension Draft Released

Turkey's KKDIK End-of -2023 Deadline Approaching, Lead Registration Slow

Latest developments

Key Illustration of Railway Transportation Regulations for Consumer Lithium Battery Cargo

Recently, the Ministry of Industry and Information Technology of the National Railway Administration China National Railway Group Co., Ltd. announced the guidance on the railway transportation of consumer lithium battery goods. For details, please refer to our public article. Official

Answers to Frequently Asked Questions about the Environmental Management Measures for New Chemical Substances (Order No.7)

I recommend: For pre-registration projects with large tonnage and short grace period, or small tonnage pre-registration projects that are clearly registered in the future, it is recommended to choose joint registration and join the joint registration IT system agreement this time. For pre-registration projects that are clearly not registered in the future, it is recommended to choose subsequent registration. May I ask you

Cancellation of GMP certification means stricter supervision of drug production?

The cumbersome process of GMP and GSP certification has made many pharmaceutical manufacturers and distribution companies feel the strict supervision of the pharmaceutical industry. On September 25, 2019, the State Food and Drug Administration issued a notice on the study, publicity and implementation of the the People's Republic of China Drug Administration Law., It is clearly proposed to strengthen dynamic supervision and cancel the drug production quality management practice (GMP) certification and the drug business quality management practice (GSP) certification.